Also, since we don’t have symptoms onset information for the symptomatic COVID-19 patients, we don’t know exactly the delay between the onset of the symptoms and lipidomics measurements, which could influence sphingosine and acid ceramidase levels. Here, ASAH1 is linked to COVID-19.